Envair Technology offers the widest portfolio of clean air and containment solutions that facilitate drug development and manufacturing in the pharmaceutical sector.
From hospital pharmacies making up personalised oncology treatments, development laboratories pioneering new gene therapies or contract manufacturers tasked with producing medicines containing high potent APIs, our range of isolators, safety cabinets and fume cupboards will deliver the clean air environment you need.
A history of innovation
Envair Technology was formed in 2019 after the acquisition of Envair and then TCS in 2020. In April 2024, the integration of these three trusted brands was completed, with all products and services rebranding to the Envair Technology name and new logo going forward.
Both original brands have long standing reputations for excellence in their respective fields and the combined strength of the group further enhances our ability to meet client needs. With double digit sales growth, clients including AstraZeneca, Pfizer, the NHS and Oxford University continue to put their trust in us. Whilst the names may have changed, the company values and high standards remain steadfast.
Our 80+ strong workforce is largely drawn from the North West of England, where skills and expertise in pharmaceuticals and manufacturing are in strong supply. This allows us to focus on quality and innovation; we are certified to ISO 9001 standards and have won several awards including being one of the Design Council's Millennium Products. We are also included on the Modern Methods of Construction (MMC) manufacturer database which recognises our commitment to sustainability.
